Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study

Lim, Hyun; Park, Jong Kyu; Chung, Hyunsoo; Lee, Si Hyung; Park, Jae Myung; Park, Jung Ho; Kim, Gwang Ha; Shin, Sung Kwan; Hong, Su Jin; Lee, Kwang Jae; Park, Moo In; Jung, Hye-Kyung; Kim, Hyun-Soo; Sung, Jae Kyu; Jeon, Seong Woo; Choi, Suck Chei; Moon, Jeong Seop; Kim, Nayoung; Park, Jong-Jae; Hong, Sung Hee; Kim, Na Young; Jung, Hwoon-Yong

doi:10.1186/s12876-023-03087-6

BMC Gastroenterology

Article metrics
Last updated: Sat, 18 May 2024 8:50:27 Z

Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study

Access & Citations

1229

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-230X

Contact us

Submission enquiries: bmcgastroenterology@biomedcentral.com
General enquiries: ORSupport@springernature.com